Elevance Health, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $199.1B | $177.0B | $171.3B | $156.6B | $138.6B |
| Operating income | $7.2B | $7.9B | $8.5B | $8.3B | $7.6B |
| Cash from operations | $4.3B | $5.8B | $8.1B | $8.4B | $8.4B |
| Capital expenditure | $1.1B | $1.3B | $1.3B | $1.2B | $1.1B |
| Free cash flow | $3.2B | $4.6B | $6.8B | $7.2B | $7.3B |
| Share repurchases | $2.6B | $2.9B | $2.7B | $2.3B | $1.9B |
| Impairments | $108.0M | $103.0M | $446.0M | $7.0M | $73.0M |
| Total assets | $121.5B | $116.9B | $108.9B | $102.8B | $97.5B |
| Total liabilities | $77.5B | $75.5B | $69.5B | $66.4B | $61.3B |
Shares outstanding 217.2M · Free float 99.8%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.
Recent filings
- June 10, 2026 8-K
- May 13, 2026 8-K
- April 22, 2026 10-Q
- April 22, 2026 8-K
- March 10, 2026 8-K
- March 2, 2026 8-K
- February 26, 2026 8-K
- February 6, 2026 10-K